
Latest News
2021-03-09 17:00:38
Meeting discusses COVID-19 vaccine manufacturing bottlenecks that must be urgently tackled for C19 vaccine output to reach its full potential
9 March 2021: Chatham House, in collaboration with COVAX, IFPMA, DVCMN, and BIO, convened a Global COVID-19 Vaccine Supply Chain & ...
Read More2021-02-18 14:00:30
The AMR Action Fund announces its first non-industry investments, raising an additional US$140 million toward addressing antimicrobial resistance (AMR)
The AMR Action Fund, launched in July 2020, aims to bring 2 to 4 new ...
Read More2021-02-18 14:00:21
The AMR Action Fund announces appointment of CEO, Henry B. Skinner, PhD
Dr. Skinner will help ensure the AMR Action Fund achieves its mission to bring two ...
Read More2021-02-05 15:02:40
Patients, product development partnerships and private health sector representatives call for the rapid ratification of the African Medicines Agency Treaty to speed up timelines to vaccines and medicines approval
London / Geneva, 5 February 2021 – On the eve of the 34th African Union ...
Read More2021-01-25 07:00:01
Biopharmaceutical global body kicks off 2021 with new CEO leadership line up
Geneva, 25 January 2021 –The biopharmaceutical global industry, represented by the International Federation of Pharmaceutical Manufacturers ...
Read More2021-01-12 11:27:48
Speak Up Africa and IFPMA start their search for winners of the Africa Young Innovators for Health Award
The Africa Young Innovators for Health Award is IFPMA and Speak Up Africa’s flagship programme ...
Read More2020-12-08 12:45:58
Speak Up Africa and IFPMA launch the “Africa Young Innovators for Health Award” to fuel innovation and help advance promising healthcare solutions
The first edition of the “Africa Young Innovators for Health Award” aims to support entrepreneurs ...
Read More
Latest Statement
2021-04-15 10:41:32
IFPMA statement at WTO event “COVID-19 and Vaccine Equity: What can the WTO Contribute”
On 14 April 2021, IFPMA and a number of its member company experts attended the WTO event “COVID-19 and Vaccine ...
Read More2021-04-09 17:36:46
BIO-IFPMA Comment on COVAX No-Fault Compensation Program for COVAX Advance Market Commitment Eligible Economies
The first edition of the “Africa Young Innovators for Health ...
Read More2021-03-30 18:20:03
COVID-19 vaccine and treatment innovators response to global leaders urgent call for international pandemic treaty
The first edition of the “Africa Young Innovators for Health ...
Read More2021-02-05 15:11:21
Call to Heads of State of the African Union to Ratify the African Medicines Agency Treaty
The first edition of the “Africa Young Innovators for Health ...
Read More2021-01-29 20:47:55
IFPMA Statement on EU COVID-19 Vaccines Supply
The first edition of the “Africa Young Innovators for Health ...
Read More2021-01-20 11:00:22
IFPMA, GSCF, ICBA Joint Statement on the item 14.2 Strengthening preparedness for health emergencies: implementation of the IHR @EB148
The first edition of the “Africa Young Innovators for Health ...
Read More2021-01-19 08:25:31
IFPMA Statement for EB148 agenda item 14.1 Covid-19 Response
The first edition of the “Africa Young Innovators for Health ...
Read More
mailto:a.jones@ifpma.org
Abigail Jones - Director, Communications
Abigail Jones is responsible for communications at IFPMA. She joined IFPMA after over 25 years in international communications and public affairs consultancy, where she worked for many blue-chip companies, trade associations, think tanks, coalition and advocacy groups. Abigail supported the launches and ongoing work of the Fight the Fakes campaign, AMR Industry Alliance and Pat-INFORMED.

mailto:m.depol@ifpma.org
Twitter @MorganePol
Morgane De Pol - Deputy Director, Communications
Morgane develops and implements public affairs programs that build trust, dialogue and collaboration between the innovative biopharmaceutical industry and other global players in the health community. Morgane has international experience in developing and rolling-out integrated advocacy and communications strategies in the global health sector, with specific focus on institutional communications, media relations, alliance building and event management.
News Release

Meeting discusses COVID-19 vaccine manufacturing bottlenecks that must be urgently tackled for C19 vaccine output to reach its full potential
9 March 2021: Chatham House, in collaboration with COVAX, IFPMA, DVCMN, and BIO, convened a Global COVID-19 Vaccine Supply Chain & Manufacturing Summit on 8th and 9th March. The unprecedented scaling up of vaccine manufacturing, from zero to billions of
Read More